40
Participants
Start Date
September 30, 2025
Primary Completion Date
September 30, 2026
Study Completion Date
December 31, 2026
Gliflozin
Our study will enroll non diabetic patients affected by chronic kidney disease secondary to lupus nephritis and ANCA associated vasculitis. Other studies have so far investigated only diabetic patients affected by the above mentioned diseases.
Federico II University
OTHER